Feb 26, 2026 07:45AM
Feb 10, 2026 04:10PM
Jan 8, 2026 07:05AM
Dec 19, 2025 09:06AM
Nov 6, 2025 08:18AM
Nov 6, 2025 07:52AM
Sep 17, 2025 04:04AM Goldman Sachs Starts Entrada Therapeutics (TRDA) at Early-Stage Biotech
Sep 5, 2025 07:00AM
Aug 7, 2025 08:45AM
Aug 6, 2025 07:56AM
Jun 3, 2025 07:03AM
Jun 2, 2025 06:54AM
May 28, 2025 07:01AM
May 8, 2025 04:54PM Entrada Therapeutics, Inc. (TRDA) Tops Q1 EPS by 31c
Mar 31, 2025 06:44AM
Mar 25, 2025 06:51AM
Mar 24, 2025 01:50PM
Mar 24, 2025 09:15AM
Mar 24, 2025 07:01AM
Mar 3, 2025 06:01AM
Feb 28, 2025 12:43AM Oppenheimer Reiterates Outperform Rating on Entrada Therapeutics (TRDA)
Feb 25, 2025 06:49AM
Feb 24, 2025 07:00AM
Feb 4, 2025 06:41AM
Feb 3, 2025 07:00AM
Dec 6, 2024 08:41AM
Nov 6, 2024 07:44AM
Nov 6, 2024 06:48AM Entrada Therapeutics (TRDA) PT Raised to $20 at H.C. Wainwright
Nov 5, 2024 04:08PM
Oct 9, 2024 07:01AM
Sep 24, 2024 07:03AM
Aug 14, 2024 12:14PM
Aug 13, 2024 07:51AM
Jun 25, 2024 06:39AM
Jun 24, 2024 02:09PM TD Cowen Reiterates Buy Rating on Entrada Therapeutics (TRDA)
Jun 24, 2024 07:15AM
Jun 24, 2024 06:00AM

353,174 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All